higher Killip class (p values < 0.05) than those followed. Written informed consent was collected, and the study was approved by the CNUH Review Board.
tests. To investigate interactive effects, associations of SLEs and SSDs with depressive status were initially stratified by 5-HTTLPR genotype, followed by tests for interactions of SLEs × 5-HTTLPR and SSDs × 5-HTTLPR in multivariate logistic regression models after adjusting for covariates associated with depressive disorder at baseline at p < 0.05. All analyses were performed using SPSS 18.0.
Depressive disorder at baseline was significantly (p < 0.05) associated with female sex, lower education, living alone, rented housing, current unemployment, hypertension, diabetes, and current smoking, and these were used as covariates in the adjusted analyses. SLEs and high SSDs were significantly associated with all baseline and follow-up depressive disorders (p < 0.05). The 5-HT-TLPR s allele was significantly associated with baseline depressive disorder and follow-up depressive disorder in those with baseline depressive disorder (p < 0.05). Figure 1 presents data for relationships of SLEs and SSDs with depressive disorder status stratified by genotype. The presence of SLEs was significantly associated with baseline depressive disorder in the presence of the s/s genotype and with follow-up depressive disorder in both baseline Depression is common following acute coronary syndrome (ACS), with shared risk factors including social exposures, such as stressful life events (SLEs) and social support deficits (SSDs) which are associated with depression [1] , ACS [2] , and their comorbidity [3] . The serotonin transporter gene-linked promoter region (5-HTTLPR) s/l polymorphism may modulate the association between psychosocial risk factors and depression with the s allele decreasing serotonin transporter gene expression and increasing depression susceptibility to SLEs [4] and SSDs [5] . To our knowledge, this has not been investigated longitudinally for depression following ACS.
We consecutively recruited 1,152 patients from 2006 to 2013 who were hospitalized at the Department of Cardiology, Chonnam National University Hospital (CNUH), Gwangju, Republic of Korea, within 2 weeks of ACS; all participants were re-approached 1 year after the baseline evaluation to investigate both acute and chronic phases. At both examinations, depressive disorder diagnoses were determined by the study psychiatrists using the Mini-International Neuropsychiatric Interview, a structured diagnostic interview for DSM-IV, defining major and minor depressive disorders [6] . From the 2 evaluations, we defined 3 binary variables: depressive disorder at baseline, depressive disorder at follow-up in those without depressive disorder at baseline, and depressive disorder at follow-up in those with depressive disorder at baseline. Since ACS patients are usually discharged from hospital within 2 weeks, after intensive medical treatment, criteria applied for depressive disorder diagnosis did not require a 2-week minimum symptom duration at baseline but required this at the follow-up, as is conventional. At baseline, 969 (378 with DSM-IV depressive disorder and 591 without) agreed to phlebotomy and represented the baseline sample. Of these, 711 were successfully followed at 1 year; depressive disorder at follow-up was present in 53 (12%) of the 426 who did not have depressive disorder at baseline, and in 130 (46%) of the 285 who had depressive disorder at baseline. The 258 who were lost to follow-up had significantly older age and a groups in the presence of the l/s and s/s genotypes. High SSDs were significantly associated with baseline depressive disorder in the presence of the s/s genotype and with follow-up depressive disorder in those with baseline depressive disorder in the presence of the l/s and s/s genotypes. There were significant interactive effects of SLEs × 5-HTTLPR on baseline depressive disorder [interaction term OR = 1.68 (95% CI = 1.08-2.64); p = 0.032] and of SSDs × 5-HTTLPR on follow-up depressive disorder in those with baseline depressive disorder [OR = 1.92 (95% CI = 1.05-3.72); p = 0.036] in the adjusted logistic regression models. All analyses were repeated after excluding participants reporting a history of previous depression (n = 34), and no substantial differences were found in any models (data not shown).
Our findings confirm the well-documented associations between unfavorable social environments and depression risk, both in patients with ACS [4] and in the general population [1] . Our findings also replicate previous studies in the association between the 5-HTTLPR s allele and depression in ACS [9] , and with respect to the interactive effects of genes and environment on depression risk [4, 5] . However, our study also presents novel findings with respect to time-specific interactions between social factors and 5-HTTLPR on depression at both acute and chronic phases after ACS: there was a significant interactive effect of SLEs and 5-HTTLPR on depressive disorder within 2 weeks of ACS and a significant interactive effect of SSDs and 5-HTTLPR on depressive disorder at 1 year in those with baseline depressive disorder.
These different patterns of genetic-environmental interactions on depression at acute and chronic phases after ACS may be explained by the nature of unfavorable environments. SLEs are strong risk factors for the onset of depression, but their long-term effects depend on the chronicity of these events [10] . Moreover, acute ACS itself represents a severe life stress when invasive diagnostic and treatment methods are involved. The synergistic effects of SLEs and the 5-HTTLPR s allele on depression may exert a powerful effect in the acute phase of ACS. In contrast, SSDs tend to be stable rather than variable over time, and are therefore well-known predictors of depression persistence [1] . The interaction of SSDs and the 5-HTTLPR s allele on depression may be particularly prominent in the chronic phase of ACS, when general health and functioning become stronger determinants of mood states. However, it is important to bear in mind the single follow-up examination which will not have captured depressive symptom trajectories over 1 year between examinations. Additionally, participants with a severer baseline pathology were more frequently lost to followup, which might obscure underlying associations. Moreover, symptom duration criteria for depressive disorder at baseline were not standard, although similar criteria have been used in previous evaluations of ACS patients in the acute phase.
Comorbid depression with ACS results in a high disease burden and is difficult to treat. Simple evaluations of SLEs and SSDs among ACS patients may be helpful in screening for depression not only at the acute phase, but also at chronic phases. When combined with 5-HTTLPR genotyping, such screening may result in more focused and time-specific interventions for the prevention or management of depression in susceptible ACS subgroups. Depressive disorder status according to SLEs, SSDs, and 5-HTTLPR. * * p < 0.01 and * * * p < 0.001 using χ 2 tests to test the associations of SLEs/SSDs with depressive disorder outcomes for each 5-HTTLPR genotype. a Depressive disorder at baseline. b Depressive disorder at follow-up in those without depressive disorder at baseline. c Depressive disorder at follow-up in those with depressive disorder at baseline. Interactions (Ix.) of SLEs × 5-HTTLPR and SSDs × 5-HTTLPR on depressive status were examined using multivariate logistic regression models after adjusting for gender, education, housing, current employment, hypertension, diabetes, and current smoking for analyses on a and b , plus treatment status for analyses on c .
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